Faron Pharmaceuticals OY — RNS

Regulatory news across FARN

Date	Time	Date	TitleTitle (filtered)	Source
05/12/16	07:00:18	5 Dec 2016	PDMR Shareholding	PDMR Shareholding	RNS
21/11/16	07:00:11	21 Nov 2016	Grant of options	Grant of options	RNS
31/10/16	07:00:10	31 Oct 2016	New Application Accepted by Finnish Patent Office	New Application Accepted by Finnish Patent Office	RNS
24/10/16	08:00:07	24 Oct 2016	First patient recruited in Japanese Ph III trial	First patient recruited in Japanese Ph III trial	RNS
07/10/16	14:41:40	7 Oct 2016	Notification of Major Interest in Shares	Notification of Major Interest in Shares	RNS
06/10/16	11:00:02	6 Oct 2016	Notification of Major Interest in Shares	Notification of Major Interest in Shares	RNS
05/10/16	18:10:06	5 Oct 2016	Notification of Major Interest in Shares	Notification of Major Interest in Shares	RNS
26/09/16	16:59:23	26 Sept 2016	Director Dealing	Director Dealing	RNS
21/09/16	12:27:10	21 Sept 2016	Raises £8.0 M through a Placing and Subscription	Raises £8.0 M through a Placing and Subscription	RNS
20/09/16	08:00:12	20 Sept 2016	Proposed Placing & Subscription to raise £8M	Proposed Placing & Subscription to raise £8M	RNS
05/09/16	08:00:06	5 Sept 2016	Interim Results for six months ended 30 June 2016	Interim Results for six months ended 30 June 2016	RNS
10/08/16	08:00:09	10 Aug 2016	Faron Pharmaceuticals Notice of Interim Results	Faron Pharmaceuticals Notice of Interim Results	RNS
14/06/16	08:00:07	14 Jun 2016	Faron Provides Update at R&D Day	Faron Provides Update at R&D Day	RNS
13/06/16	08:00:07	13 Jun 2016	Faron Licenses Traumakine Rights to Pharmbio Korea	Faron Licenses Traumakine Rights to Pharmbio Korea	RNS
26/05/16	11:53:56	26 May 2016	Faron Result of Annual General Meeting	Faron Result of Annual General Meeting	RNS
26/05/16	08:00:06	26 May 2016	Faron Expands R&D Strategy for Clevegen	Faron Expands R&D Strategy for Clevegen	RNS
13/05/16	08:00:07	13 May 2016	Faron Pharmaceuticals Ltd to host an R&D Day	Faron Pharmaceuticals Ltd to host an R&D Day	RNS
04/05/16	08:00:10	4 May 2016	Notice of AGM	Notice of AGM	RNS
03/05/16	08:00:22	3 May 2016	Faron Appoints New Medical Director	Faron Appoints New Medical Director	RNS
22/04/16	08:00:09	22 Apr 2016	Faron Appoints Panmure Gordon as Joint Broker	Faron Appoints Panmure Gordon as Joint Broker	RNS
19/04/16	08:00:08	19 Apr 2016	Faron Files Two New Patents to Protect Clevegen	Faron Files Two New Patents to Protect Clevegen	RNS
10/03/16	07:00:06	10 Mar 2016	Annual Results for the year ended 31 December 2015	Annual Results for the year ended 31 December 2015	RNS
01/03/16	07:00:08	1 Mar 2016	Faron files patent application for Traumakine	Faron files patent application for Traumakine	RNS
10/02/16	07:00:08	10 Feb 2016	Notice of Preliminary Results	Notice of Preliminary Results	RNS
07/01/16	07:00:05	7 Jan 2016	Top-line results from Japanese study of Traumakine	Top-line results from Japanese study of Traumakine	RNS
29/12/15	07:00:14	29 Dec 2015	First Patient recruited in Phase III ARDS Study	First Patient recruited in Phase III ARDS Study	RNS
21/12/15	07:00:08	21 Dec 2015	Faron Awarded ?1.5 million Tekes Funding	Faron Awarded ?1.5 million Tekes Funding	RNS
30/11/15	07:00:08	30 Nov 2015	Key Publication in Journal of Immunology	Key Publication in Journal of Immunology	RNS
17/11/15	07:30:02	17 Nov 2015	Admission to AIM and first day of dealings	Admission to AIM and first day of dealings	RNS

Showing 501–529 of 529 announcements